Actively Recruiting
Study to Confirm Long-Term Safety and Effectiveness of RADIESSE Injectable Implant for Moderate to Severe Nasolabial Folds
Led by Merz North America, Inc. · Updated on 2026-10-29
163
Participants Needed
8
Research Sites
78 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the long-term safety, effectiveness, and breakdown of RADIESSE Injectable Implant for treating moderate to severe nasolabial folds NLFs in Chinese adults. The study focuses on confirming how well this implant improves wrinkle severity and overall aesthetic appearance over time. Participants will receive a single injection of RADIESSE into both nasolabial folds on the first day. At the investigators discretion, an optional touch-up injection may be given one month later. The treatment follows current product guidelines and instructions. After the last treatment, participants will be monitored for up to 24 months. During the study, participants will be assessed using scales that measure wrinkle severity and aesthetic improvement, both by the investigator and by the participant. The primary outcome is the percentage of participants achieving at least a one-point improvement in wrinkle severity six months after the last treatment. Safety and effectiveness will be closely tracked throughout the follow-up period.
CONDITIONS
Brief Title
A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds
Research Team
P
Public Disclosure Manager
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here